UnitedHealth Group Statement on Trump Administration's Drug Policy Proposal

MINNETONKA, Minn.--()--Today, UnitedHealth Group released the following statement on the Trump Administration’s drug policy proposal:

“The fundamental issues with prescription drug affordability are the high prices set by and marketing practices of pharmaceutical manufacturers, so we welcome the Administration’s focus on reducing drug costs. UnitedHealth Group remains committed to offering concrete solutions to further protect consumers from rising drug prices and building programs to help make prescription drug costs more affordable, predictable and stable – programs like our industry-first initiative to provide point of sale pharmacy discounts for our commercial customers, and our application of advanced technology to provide drug cost transparency right in the doctor’s office.”

About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a diversified health and well-being company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. For more information, visit UnitedHealth Group at http://www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.

Click here to subscribe to Mobile Alerts for UnitedHealth Group.

Contacts

UnitedHealth Group
L.D. Platt, 202-413-7763
or
OptumRx
Drew Krejci, 612-716-3980

Release Summary

UnitedHealth Group issues statement on Trump Administration's drug policy proposal.

Contacts

UnitedHealth Group
L.D. Platt, 202-413-7763
or
OptumRx
Drew Krejci, 612-716-3980